CAXTON CORP
Top Portfolio Positions
7 positions ·
$4,024,567 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| GLD |
Spdr Gold Trust
|
7,623 | $3,280,100 | 81.50% | |
| BRK-B |
Berkshire Hathaway Inc
Financial Services
|
727 | $348,378 | 8.66% | |
| KYTX |
Kyverna Therapeutics, Inc.
Healthcare
|
18,773 | $162,010 | 4.03% | |
| LXEO |
Lexeo Therapeutics, Inc.
Healthcare
|
13,943 | $80,032 | 1.99% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
15,557 | $64,250 | 1.60% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
28,453 | $47,801 | 1.19% | |
| ALXO |
Alx Oncology Holdings Inc
Healthcare
|
20,946 | $41,996 | 1.04% |
Portfolio Trend
25 quarters · across all stocks
Holdings in SABS
Shares Held
Position Value (USD)
2 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $39,370 | 10,527 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $21,979 | 10,935 | Shares | Sole | 2025-11-14 | |
| No 13F history on record for this holder in this stock. | ||||||